The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-10 of 10 articles
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Dangas G,
Baber U,
Sharma S,
Giustino G,
Sartori S,
Nicolas J,
Goel R,
Mehta S,
Cohen D,
Angiolillo D,
Zhang Z,
Camaj A,
Cao D,
Briguori C,
Dudek D,
Escaned J,
Huber K,
Collier T,
Kornowski R,
Kunadian V,
Moliterno D,
Ohman EM,
Weisz G,
Gil R,
Krucoff M,
Kaul U,
Oldroyd K,
Sardella G,
Shlofmitz R,
Witzenbichler B,
Kastrati A,
Han Y,
Steg PG,
Pocock S,
Gibson CM,
Mehran R
March 18, 2022 | 10.4244/EIJ-D-21-00721
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study
Asano T,
Kogame N,
Onuma Y,
Modolo R,
Chichareon P,
Lefèvre T,
Legutko J,
Digne F,
Morel M,
Serruys P,
Gil R
October 23, 2020 | 10.4244/EIJ-D-19-00361
Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study
Vassilev D,
Dosev L,
Collet C,
Karamfiloff K,
Stoikova J,
Pancheva R,
Shumkova M,
Zlatancheva G,
Naunov V,
Rigatelli G,
Kassab G,
Gil R,
Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00189
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial
Gil R,
Bil J,
Grundeken M.J,
Kern A,
Iñigo Garcia L,
Vassilev D,
Pawłowski T,
Formuszewicz R,
Dobrzycki S,
Wykrzykowska JJ,
Serruys P
December 9, 2016 | 10.4244/EIJY15M11_11
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry
Gil R,
Bil J,
Grundeken M.J,
Iñigo Garcia L,
Vassilev D,
Kern A,
Pawłowski T,
Wykrzykowska JJ,
Serruys P
November 20, 2016 | 10.4244/EIJY15M10_05
Dedicated stents for distal left main stenting
May 19, 2015 | 10.4244/EIJV11SVA29
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population
Gil R,
Vassilev D,
Michalek A,
Kern A,
Formuszewicz R,
Dobrzycki S,
Wójcik J,
Lesiak M,
Kardaszewicz P,
Lekston A
July 27, 2012 | 10.4244/EIJV8I3A50
Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model
September 30, 2011 | 10.4244/EIJV7I5A98
Latest news
AHEAD OF PRINT
Cerebral embolic protection in TAVI
FREE ARTICLE - Rajesh K. Kharbanda et al
January 26, 2023
AHEAD OF PRINT
First experience of LAAO using a 3D mini TOE probe with conscious sedation
FREE ARTICLE - Laura Sanchis et al
January 25, 2023
AHEAD OF PRINT
“Lotus root”: a novel OCT imaging pattern in spontaneous coronary artery dissection
FREE ARTICLE - David del Val et al
January 20, 2023
NEW ISSUE
M-TEER State-of-the-Art; Comparing ACURATE Neo2 to Evolut PRO/PRO + and the SAPIEN 3 Ultra; Mini Focus on Vulnerable Plaque: Plaque Composition and Vulnerability – Radial Wall Strain...
January 23, 2023
AHEAD OF PRINT
Antiplatelet therapy following PCI for stable CAD
FREE ARTICLE - Anoop N. Koshy et al
January 19, 2023
AHEAD OF PRINT
FAVOR III Europe Japan trial design
FREE ARTICLE - Birgitte Krogsgaard Andersen et al
January 17, 2023
AHEAD OF PRINT
SinoCrown TAVI system study
FREE ARTICLE - Qingrong Liu et al
January 16, 2023